Evidence map›Paper›PMID 26744140›Full record

ArticleLiver international : official journal of the International Association for the Study of the Liver2016

Prospective comparison of magnetic resonance imaging to transient elastography and serum markers for liver fibrosis detection.

Hadrien A Dyvorne, Guido H Jajamovich, Octavia Bane, M Isabel Fiel, Hsin Chou, Thomas D Schiano, Douglas Dieterich, James S Babb, Scott L Friedman, Bachir Taouli

Registry-linked trialOpen access · greenAbstract readComparative Study
In one paragraph

Article in Liver international : official journal of the International Association for the Study of the Liver, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01600105 (Prospective Detection of Liver Fibrosis With MRI Compared to Fibroscan and Blood Tests), which is not on this map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01600105 phase4completednot on this map

Prospective Detection of Liver Fibrosis With MRI Compared to Fibroscan and Blood Tests

TypeinterventionalSponsorBachir TaouliRan2010 to 2017Enrolled276ConditionsChronic Liver DiseaseArmsPerfusion MRI
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Noninvasive imaging assessment of portal hypertension.Abdominal radiology (New York) · 2020
    Review
  18. Article
  19. Targeting metabolic dysregulation for fibrosis therapy.Nature reviews. Drug discovery · 2020
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Hadrien A DyvorneTranslational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Guido H JajamovichTranslational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Octavia BaneTranslational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
M Isabel FielDepartment of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Hsin ChouDepartment of Medicine, Division of Liver Diseases, Mount Sinai School of Medicine, New York, NY, USA.
Thomas D SchianoDepartment of Medicine, Division of Liver Diseases, Mount Sinai School of Medicine, New York, NY, USA.
Douglas DieterichDepartment of Medicine, Division of Liver Diseases, Mount Sinai School of Medicine, New York, NY, USA.
James S BabbDepartment of Radiology, New York University Langone Medical Center, New York, NY, USA.
Scott L FriedmanDepartment of Medicine, Division of Liver Diseases, Mount Sinai School of Medicine, New York, NY, USA.
Bachir TaouliTranslational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Icahn School of Medicine at Mount Sinai · USImaging Center · USNYU Langone Health · US

Funding

The Role of KLF6 in Hepatic FibrosisR01DK056621 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI FRIEDMAN, SCOTT L. · 2000 to 2019
$6.2M
Autophagy during hepatic stellate cell activation in alcoholic liver injuryR01AA020709 · NIAAA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI FRIEDMAN, SCOTT L. · 2011 to 2015
$1.8M
Detection of Liver Fibrosis Using IVIM Diffusion and DCE MRI in HCVR01DK087877 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI TAOULI, BACHIR · 2010 to 2014
$1.8M
Hepatic autophagy, progenitor cells and fibrosisR56DK056621 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI FRIEDMAN, SCOTT L. · 2015 to 2015
$297k
NIAAA NIH HHS R01 AA020709NIDDK NIH HHS R01 DK056621NIDDK NIH HHS R01 DK087877NIDDK NIH HHS R56 DK056621
6 · The paper itself

Abstract

BACKGROUND &

aimsEstablishing accurate non-invasive methods of liver fibrosis quantification remains a major unmet need. Here, we assessed the diagnostic value of a multiparametric magnetic resonance imaging (MRI) protocol including diffusion-weighted imaging (DWI), dynamic contrast-enhanced (DCE)-MRI and magnetic resonance elastography (MRE) in comparison with transient elastography (TE) and blood tests [including ELF (Enhanced Liver Fibrosis) and APRI] for liver fibrosis detection.

methodsIn this single centre cross-sectional study, we prospectively enrolled 60 subjects with liver disease who underwent multiparametric MRI (DWI, DCE-MRI and MRE), TE and blood tests. Correlation was assessed between non-invasive modalities and histopathologic findings including stage, grade and collagen content, while accounting for covariates such as age, sex, BMI, HCV status and MRI-derived fat and iron content. ROC curve analysis evaluated the performance of each technique for detection of moderate-to-advanced liver fibrosis (F2-F4) and advanced fibrosis (F3-F4).

resultsMagnetic resonance elastography provided the strongest correlation with fibrosis stage (r = 0.66, P < 0.001), inflammation grade (r = 0.52, P < 0.001) and collagen content (r = 0.53, P = 0.036). For detection of moderate-to-advanced fibrosis (F2-F4), AUCs were 0.78, 0.82, 0.72, 0.79, 0.71 for MRE, TE, DCE-MRI, DWI and APRI, respectively. For detection of advanced fibrosis (F3-F4), AUCs were 0.94, 0.77, 0.79, 0.79 and 0.70, respectively.

conclusionsMagnetic resonance elastography provides the highest correlation with histopathologic markers and yields high diagnostic performance for detection of advanced liver fibrosis and cirrhosis, compared to DWI, DCE-MRI, TE and serum markers.

Indexed as

Diffusion Magnetic Resonance ImagingElasticity Imaging TechniquesAdultArea Under CurveBiomarkersCross-Sectional StudiesFemaleHumansLiverLiver CirrhosisLogistic ModelsMaleMiddle AgedNew YorkProspective StudiesReproducibility of ResultsBiomarkersdiffusion-weighted imagingdynamic contrast-enhanced MRIelastographyliver fibrosismagnetic resonance imaging

Identifiers

PMID26744140
PMCPMC4842106
OpenAlexW2225220720

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.